Skip to main content
. 2023 Jul 21;56:e12636. doi: 10.1590/1414-431X2023e12636

Table 3. Indirect immunofluorescence-antineutrophil cytoplasmic antibodies (IIF-ANCA) features of tests performed at the Immuno-Rheumatology laboratory and in independent laboratories at diagnosis.

IIF-ANCA GPA MPA EGPA RLV Type 1 AIH UC
Tests performed at Immuno-Rheumatology laboratory 15 4 5 1 3 3
Positive tests, n (%) 5 (33.3) 2 (50.0) 0 (0.0) 1 (100.0) 1 (33.3) 1 (33.3)
C-ANCA, n (%) 5 0 0 0 0 1
P-ANCA, n (%) 0 1 0 1 0 0
A-ANCA, n (%) 0 1 0 0 1 0
Tests performed in outside laboratories 7 3 1 0 1 0
Positive tests, n (%) 5 (71.4) 3 (100.0) 0 (0.0) - 1 (100.0) -
C-ANCA, n (%) 4 2 0 - 0 -
P-ANCA, n (%) 1 1 0 - 0 -
A-ANCA, n (%) 0 0 0 - 1 -

AIH: autoimmune hepatitis; EGPA: eosinophilic granulomatosis with polyangiitis; GPA: granulomatosis with polyangiitis; MPA: microscopic polyangiitis; RVL: renal limited vasculitis; UC: ulcerative colitis; n: number of patients. The total number of tests performed at the Immuno-Rheumatology laboratory was 31 while 12 tests were performed in independent laboratories at diagnosis.